Condition

Neoplasms, Squamous Cell

ClinicalTrials.gov condition label

Clinical trials3

Recruiting0

Common interventions7

Lead sponsors shown3

Clinical trials

3 shown

PF-06952229 Treatment in Adult Patients With Advanced Solid TumorsNCT03685591 · 2018-10-04

TERMINATED

Safety Study of SEA-CD40 in Cancer PatientsNCT02376699 · 2015-02-28

TERMINATED

Modeling Study to Predict Progression of Anal Cancer Pre-cursor Lesions in HIVNCT01709448 · 2009-01-01

UNKNOWN

Common interventions

EnzalutamideDRUG1GemcitabineDRUG1Intravenous (IV) SEA-CD40DRUG1Nab-paclitaxelDRUG1PembrolizumabDRUG1PF-06952229DRUG1Subcutaneous (SC) SEA-CD40DRUG1

Leading sponsors

National Institute of Allergy and Infectious Diseases (NIAID)1Pfizer1Seagen Inc.1

Trial status mix

TERMINATED2

UNKNOWN1

Phase mix

PHASE12

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.